Discover more insights into Axitinib Versus

Keywords frequently search together with Axitinib Versus

Narrow sentence examples with built-in keyword filters

Axitinib Versus sentence examples within Plu Axitinib Versus



Efficacy and correlative analyses of avelumab plus axitinib versus sunitinib in sarcomatoid renal cell carcinoma: post hoc analysis of a randomized clinical trial



Editorial Comment from Dr Hatakeyama and Dr Ohyama to Clinical utility of head computed tomography scan during systemic therapy for metastatic renal cell carcinoma


Axitinib Versus sentence examples within axitinib versus sunitinib



Pembrolizumab + axitinib likely most cost-effective option for advanced RCC in the USA



Efficacy and correlative analyses of avelumab plus axitinib versus sunitinib in sarcomatoid renal cell carcinoma: post hoc analysis of a randomized clinical trial


Axitinib Versus sentence examples within axitinib versus sorafenib



Is Axitinib Still a Valid Option for mRCC in the Second-Line Setting? Prognostic Factor Analyses From the AXIS Trial.



First-line axitinib versus sorafenib in Asian patients with metastatic renal cell carcinoma: exploratory subgroup analyses of Phase III data.



Learn more from Axitinib Versus


More Axitinib Versus sentence examples
10.1007/s40274-021-08074-x

Pembrolizumab + axitinib likely most cost-effective option for advanced RCC in the USA


More Axitinib Versus sentence examples
10.1016/j.esmoop.2021.100101

Efficacy and correlative analyses of avelumab plus axitinib versus sunitinib in sarcomatoid renal cell carcinoma: post hoc analysis of a randomized clinical trial



Clinical Results and Biomarker Analyses of Axitinib and TRC105 versus Axitinib Alone in Patients with Advanced or Metastatic Renal Cell Carcinoma (TRAXAR).



Editorial Comment from Dr Hatakeyama and Dr Ohyama to Clinical utility of head computed tomography scan during systemic therapy for metastatic renal cell carcinoma


More Axitinib Versus sentence examples
10.1016/j.esmoop.2021.100105

ATLAS trial of adjuvant axitinib in patients with renal cell carcinoma: subgroup analyses with focus on axitinib dosing and racial groups



Randomized Phase II Study of Axitinib Versus Observation in Patients with Recurred or Metastatic Adenoid Cystic Carcinoma


More Axitinib Versus sentence examples
10.1038/s41571-019-0193-5

Axitinib–ICIs boost the RCC armamentarium


More Axitinib Versus sentence examples
10.1016/j.ebiom.2019.08.049

Management of metastatic renal cell carcinoma: The complexity of choice


More Axitinib Versus sentence examples
10.1007/s40261-019-00820-6

Cost-effectiveness Analysis of Pembrolizumab Plus Axitinib Versus Sunitinib in First-line Advanced Renal Cell Carcinoma in China


More Axitinib Versus sentence examples
10.1016/J.CLGC.2019.03.017

Is Axitinib Still a Valid Option for mRCC in the Second-Line Setting? Prognostic Factor Analyses From the AXIS Trial.



First-line axitinib versus sorafenib in Asian patients with metastatic renal cell carcinoma: exploratory subgroup analyses of Phase III data.


Learn more from Axitinib Versus


Axitinib Versus
Encyclopedia